Public warning against Hoxsey cancer treatment (HEW-D38), advance release for p.m. newspapers (1956)

Other · U.S. Department of Health, Education, and Welfare, Food and Drug Administration · April 4, 1956

U.S. Department of Health, 1956-04-04: The FDA's 4 April 1956 public warning, issued under 21 U.S.C. 375(b), stating that the Hoxsey treatment for internal cancer is worthless and its sale a gross deception, and giving its cost as $400 plus $60 in fees.

the so-called Hoxsey treatment for internal cancer has been found by the United States Court of Appeals for the Fifth Circuit, on the basis of evidence presented by the Food and Drug Administration, to be a worthless treatment

p. 1

U.S. Department of Health, 1956-04-04: The FDA's 4 April 1956 public warning, issued under 21 U.S.C. 375(b), stating that the Hoxsey treatment for internal cancer is worthless and its sale a gross deception, and giving its cost as $400 plus $60 in fees. Federal document, public domain, but the only copy located is an NGO scan – the PDF is an image scan with a noisy OCR layer, so the quoted words are transcribed from the scan. It cites the Fifth Circuit decisions at 198 F.2d 273 and 207 F.2d 67. Note this is a warning about worthless treatment, not evidence of suppression: the FDA acted after litigation the government won.